Eosinophilic Chronic Rhinosinusitis and Pathogenic Role of Protease

Int J Mol Sci. 2023 Dec 12;24(24):17372. doi: 10.3390/ijms242417372.

Abstract

Chronic rhinosinusitis (CRS) is an inflammation of the nasal and paranasal sinus mucosa, and eosinophilic CRS (eCRS) is a subtype characterized by significant eosinophil infiltration and immune response by T-helper-2 cells. The pathogenesis of eCRS is heterogeneous and involves various environmental and host factors. Proteases from external sources, such as mites, fungi, and bacteria, have been implicated in inducing type 2 inflammatory reactions. The balance between these proteases and endogenous protease inhibitors (EPIs) is considered important, and their imbalance can potentially lead to type 2 inflammatory reactions, such as eCRS. In this review, we discuss various mechanisms by which exogenous proteases influence eCRS and highlight the emerging role of endogenous protease inhibitors in eCRS pathogenesis.

Keywords: chronic rhinosinusitis; endogenous protease inhibitor; eosinophilic chronic rhinosinusitis; protease.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Endopeptidases
  • Eosinophils
  • Humans
  • Hypersensitivity* / pathology
  • Peptide Hydrolases
  • Protease Inhibitors
  • Rhinitis* / pathology
  • Rhinosinusitis*
  • Sinusitis* / pathology

Substances

  • Peptide Hydrolases
  • Endopeptidases
  • Protease Inhibitors